Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

once Voclosporin gets approved the possibility of a bidding war may drive the buyout to about 50.

That's about 4 billion. Not bad, but I would guess that if the DES indication works out, the value should be much higher. LN and DES each represent blockbusters, and there are other indications in the wings. If the company can wait a bit longer (10-12 months), I would expect closer to 8B for a buyout.